MEN1-KD also inhibited the mRNA levels of ATG5, SQSTM1, and MAP1LC3B and decreased the protein levels of P62 and LC3B-II in another lung cancer cells (Supplementary Fig. S2C, p < 0.05). The gene discussed is MAP1LC3B; the disease is lung carcinoma.